Literature DB >> 3446577

Procedures for enhancing the utility of the metallothionein promoter for the regulated expression of downstream open reading frames.

W E Walden1, S Daniels-McQueen, L L Smith, R E Thach.   

Abstract

Procedures which enhance the inducibility of the mouse metallothionein I (mMT-I) transcriptional promoter in mouse C127 cells transformed by bovine papilloma virus have been investigated. These include: (i) induction with Zn2+ at low serum concentration, and (ii) use of a 'superinduction' protocol (presence of 1 microgram/ml of cycloheximide during induction with Zn2+, followed by 2 micrograms/ml of actinomycin D). Use of procedure (i) alone gave a 15- to 20-fold induction of expression of a downstream open reading frame (ORF), which is comparable to the maximum inducibility achieved with mMT-I in other systems. Use of procedures (i) and (ii) in combination allowed a 50-fold induction. Three different reporter ORFs (rabbit ferritin L subunit, human chorionic gonadotropin alpha subunit, and human lutropin beta subunit), in three different chromosomal contexts, responded to these procedures. The maximum rate of expression achieved was estimated at over 10(9) molecules per cell per day, which is 20% of the transformed cell's protein synthetic capacity. At these extremely high levels some of the induced products were cytotoxic.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3446577     DOI: 10.1016/0378-1119(87)90195-8

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  2 in total

1.  Translational repression in eukaryotes: partial purification and characterization of a repressor of ferritin mRNA translation.

Authors:  W E Walden; S Daniels-McQueen; P H Brown; L Gaffield; D A Russell; D Bielser; L C Bailey; R E Thach
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

2.  Inducible expression of encephalomyocarditis virus 3C protease activity in stably transformed mouse cell lines.

Authors:  T G Lawson; L L Smith; A C Palmenberg; R E Thach
Journal:  J Virol       Date:  1989-12       Impact factor: 5.103

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.